|
|
|
| This article has been cited by | | 1 | Influenza vaccines: Evaluation of the safety profile | | | Claudia Maria Trombetta,Elena Gianchecchi,Emanuele Montomoli | | Human Vaccines & Immunotherapeutics.2018;14(3)657 | | [DOI] | | | 2 | Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam | | | Ho Vinh Thang,Vu Minh Huong,John C. Victor,Cao Bao Van,Nguyen Tuyet Nga,Le Van Be,Nguyen Phu Cuong,Vadim Tsvetnitsky,Kathleen M. Neuzil,Maureen Power,Jorge Flores | | Vaccine.2018;36(46)6918 | | [DOI] | | | 3 | Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India | | | Nagendra R. Hegde,Deepak Kumar,P. Panduranga Rao,P. Krishna Kumari,Yashpal Kaushik,R. Ravikrishnan,Sai D. Prasad,Krishna M. Ella | | Vaccine.2014;32(29)3636 | | [DOI] | | | 4 | Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children | | | Prasad S. Kulkarni,K. Manjunath,Sharad Agarkhedkar | | Vaccine.2012;31(1)20 | | [DOI] | | | 5 | Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand | | | Nuntisa Chotirosniramit,Patcharaphan Sugandhavesa,Linda Aurpibul,Sunida Thetket,Natthapol Kosashunhanan,Taweewat Supindham,Panuwat Wongkulab,Quanhathai Kaewpoowat,Kanokporn Chaiklang,Oranitcha Kaewthip,Piyathida Sroysuwan,Antika Wongthanee,Hatairat Lerdsamran,Pilaipan Puthavathana,Khuanchai Suparatpinyo | | Human Vaccines & Immunotherapeutics.2012;8(12)1854 | | [DOI] | |
|
